The Effects of Isotonic and Hypertonic Saline Infusion on Renal Biomarkers in Healthy Young Subjects
NCT01414088 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 23
Last updated 2013-05-20
Summary
The kidneys have numerous salt and water channels and play a major role in the regulation of sodium and water. We do not know how these channels work in certain water and sodium accumulating medical conditions.
The purpose of this study is to identify and measure the activity in the water and sodium channels by measuring urine biomarkers/proteins in young healthy subjects.
Conditions
- Nephropathy
Interventions
- OTHER
-
isotonic saline 0,9 mg/ml
infusion, 23 ml/kg, during 50 minutes
- OTHER
-
hypertonic saline 2,9 mg/ml
infusion, 7 ml/kg, during 50 minutes
- OTHER
-
glucose 5%
infusion, 23 ml/kg, during 50 minutes
Sponsors & Collaborators
-
Regional Hospital Holstebro
lead OTHER
Principal Investigators
-
Erling B Pedersen, Professor · Medicinsk Forskning, Regionshospitalet i Holstebro
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-04-30
- Primary Completion
- 2012-04-30
- Completion
- 2012-04-30
Countries
- Denmark
Study Locations
More Related Trials
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System
NCT02527863 ·Status: COMPLETED ·Phase: PHASE2
-
Fractional Urate Excretion in Nonedematous Hyponatremia
NCT01425125 ·Status: WITHDRAWN ·Phase: NA
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System (TORA)
NCT01638663 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Hypertonic Saline Solution on Acute Decompensated Heart Failure
NCT05298098 ·Status: UNKNOWN ·Phase: NA
-
Tissue K+ in Primary Hyperaldosteronism
NCT04251780 ·Status: COMPLETED
-
Sodium Diet Effect on Aldosterone and Urinary RNA (SALTY)
NCT04168073 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of Tolvaptan in Cirrhotic Patients With Hyponatremia
NCT01850940 ·Status: COMPLETED
-
Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.
NCT06237712 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of the Aquaretic Tolvaptan on Nitric Oxide System. A Dose-response Study (DOVA)
NCT02078973 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Low Dose Hypertonic Saline Solution and High Dose Furosemide for Congestive Heart Failure
NCT01028170 ·Status: COMPLETED ·Phase: PHASE3
-
Safety of Dialysate Sodium Individualization in Hemodialysis Patients With Intradialytic Hypotension
NCT00237783 ·Status: TERMINATED ·Phase: PHASE1
-
Cardiac Tissue Sodium Assessment in CKD Patients Using Sodium MRI
NCT04848636 ·Status: RECRUITING
-
Are we Loading Our Patients With Sodium During Hemodialysis Treatments?
NCT01454193 ·Status: COMPLETED
-
Double Blind Crossover Comparison of Diuretics in the Young
NCT00429897 ·Status: UNKNOWN ·Phase: NA
-
Lowering Salt Intake in Chronic Kidney Disease: A Pilot Randomized Crossover Trial
NCT00974636 ·Status: COMPLETED ·Phase: NA
-
"SALT Trial" Study of Ascending Levels of Tolvaptan in Hyponatremia
NCT00072683 ·Status: COMPLETED ·Phase: PHASE3
-
DD-study: Diet or Diuretics for Salt-sensitivity in Chronic Kidney Disease
NCT02875886 ·Status: COMPLETED ·Phase: PHASE4
-
Sodium-restricted Diets and Symptoms in End Stage Renal Disease: An RCT
NCT02778516 ·Status: COMPLETED ·Phase: NA
-
Effects of Tolvaptan in Healthy Adults
NCT01973140 ·Status: COMPLETED ·Phase: PHASE4
-
The Role of Skin Sodium Accumulation in Chronic Kidney Disease
NCT07020104 ·Status: RECRUITING ·Phase: NA
-
A Pharmacodynamics, Pharmacokinetics, and Safety Study of Hydrochlorothiazide and Canagliflozin in Healthy Volunteers
NCT01294631 ·Status: COMPLETED ·Phase: PHASE1
-
Effects of Exogenous Ketosis on Renal Function, Renal Perfusion, and Sodium Excretory Capacity
NCT06418074 ·Status: COMPLETED ·Phase: NA
-
The Effect of High and Low Sodium Intake on Urinary Aquaporin-2 in Autosomal Dominant Polycystic Kidney Disease
NCT00410007 ·Status: COMPLETED ·Phase: NA
-
Tissue Sodium Quantification in Patients With Primary Aldosteronism: See Sodium to Treat
NCT06569589 ·Status: RECRUITING
-
The Effect of Amiloride and Spironolactone in Healthy Persons
NCT00857909 ·Status: COMPLETED ·Phase: PHASE1